公司比较

简介

Sarepta Therapeutics is the leader in treatments for Duchenne muscular dystrophy (DMD) — a fatal muscle-wasting disease affecting young boys. Its gene therapy Elevidys is the first approved treatment to address the genetic root cause.

营收

$1.9B

新闻缺口信号

此股票代码没有新闻缺口数据。

机构信号

此代码没有13F信号记录。

级联模式

未出现在任何追踪的级联模式中。

关键关系

简介

NVIDIA is the dominant designer of graphics processing units and AI accelerator chips. Its data-center GPU monopoly powers the generative-AI revolution, with the H100 and successor Blackwell GPUs serving as the de-facto standard for training and running large language models.

营收

$130.5B

新闻缺口信号

机构信号

级联模式

关键关系